Product analysis
Hawthorn Berries 565 mg offers a simple hawthorn supplement at a favorable cost. Its unspecified preparation makes it hard to relate the contents to the extracts behind the limited heart-related evidence.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
Hawthorn’s preparation is unspecified. That prevents a clear quality comparison with identified extracts.
Ingredient Transparency63
The hawthorn amount is disclosed. Its form is omitted, making preparation differences harder to compare.
Value For Money100
Hawthorn compares favorably on serving cost. That affordability does not establish equivalence to a particular extract.
Customer Satisfaction70
Customer ratings are strongly favorable. Very few reviews make the satisfaction pattern less settled.
Product Focus73
The formula stays focused on hawthorn and related heart-health goals. Conflicting findings from specific extracts do not establish routine benefits from this generic preparation.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $0.08
- Customer rating
- 4.7 · 35 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Hawthorn | 565 mg |
How this ingredient is rated
Composition and Label Disclosure29
Marker and Preparation Disclosure
Species Name Disclosure
Composition and Label Disclosure
Commercial Price and Usability100
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.